Sumitomo Pharma Co. shares declined after a Japanese government panel endorsed a conditional approval for its regenerative therapy, built on technology pioneered by a Nobel Prize laureate.
www.bloomberg.com
#Sumitomo #Pharma #Shares #Drop #StemTherapy #Backing
Sumitomo Pharma Shares Drop After Stem-Therapy Backing
